On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...
The UK is one of the heaviest nations in Europe now with 64 per cent of the population overweight or obese, and one in four ...
Your doctor will help you decide which form, pill or injection, of Wegovy is best for you. It may depend on your medical history, which dosing schedule fits your lifestyle better, and how comfortable ...
Wegovy is a prescription medicine used for weight loss, to reduce cardiovascular risks, and to treat metabolic dysfunction-associated steatohepatitis (MASH). It is available in two forms: a liquid for ...
GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...
Chief Medical Officer at Central DuPage Hospital Dr. Tom Moran joins Bob Sirott to discuss a study that looks at the correlation between caffeine intake and the risk for diabetes, the new federal ...
A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...
Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent KFF polls, about one in eight U.S. adults takes a GLP-1 medication for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results